Phase I/II study of a combination of capecitabine, cisplatin, and intraperitonealdocetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis

被引：0
|
作者：
Cho, Hyungwoo
Ryu, Min-Hee
Yoo, Changhoon
Ryoo, Baek-Yeol
Park, Sook Ryun
Kim, Kyu-Pyo
Kim, Beom Su
Yoo, Moon-Won
Yook, Jeong Hwan
Kim, Byung Sik
Kang, Yoon-Koo
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[5] Asan Med Ctr, Dept Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4026
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Simvastatin plus capecitabine-cisplatin (XP) versus placebo plus capecitabine-cisplatin (XP) in patients with previously untreated advanced gastric cancer: A double-blind randomized phase 3 study.
    Kim, Seung
    Kang, Won Ki
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Jung Hun
    Hwang, In Gyu
    Lee, Sang-Cheol
    Park, Keon-Woo
    Lee, Hyo Rak
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [43] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
  • [44] Capecitabine/cisplatin effective in advanced gastric cancer patients
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 814 - +
  • [45] PHASE II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND CONTINUOUS CAPECITABINE (CAP) COMBINATION (DCX) IN ADVANCED GASTRIC CANCER: PRELIMINARY DATA
    Pericay, Carles
    Losa, Ferran
    Fernandez, Julen
    Alfaro, Jordi
    Pisa, Aleydis
    Salud, Antonieta
    Falco, Esther
    Vicente, Pilar
    Casado, Esther
    Saigi, Eugeni
    ANNALS OF ONCOLOGY, 2011, 22 : v48 - v48
  • [46] Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric
    Icli, F
    Karaoguz, H
    Akbulut, H
    Dincol, D
    Demirkazik, A
    Cay, F
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 64 (04) : 318 - 323
  • [47] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    W Koizumi
    S Tanabe
    K Saigenji
    A Ohtsu
    N Boku
    F Nagashima
    K Shirao
    Y Matsumura
    M Gotoh
    British Journal of Cancer, 2003, 89 : 2207 - 2212
  • [48] Randomized Prospective Phase II Study to Compare the Combination Chemotherapy Regimen Epirubicin, Cisplatin, and 5-Fluorouracil With Epirubicin, Cisplatin, and Capecitabine in Patients With Advanced or Metastatic Gastric Cancer
    Ocvirk, Janja
    Rebersek, Martina
    Skof, Erik
    Hlebanja, Zvezdana
    Boc, Marko
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 237 - 241
  • [49] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Shirao, K
    Matsumura, Y
    Gotoh, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (12) : 2207 - 2212
  • [50] Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer
    Shirao, K
    Shimada, Y
    Kondo, H
    Saito, D
    Yamao, T
    Ono, H
    Yokoyama, T
    Fukuda, H
    Oka, M
    Watanabe, Y
    Ohtsu, A
    Boku, N
    Fujii, T
    Oda, Y
    Muro, K
    Yoshida, S
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 921 - 927
12345